Application of CD34+ autologous peripheral progenitor cell transplant in the treatment of children with refractory SLE

OBJECTIVE: Systematic lupus erythematosis (SLE) is a severe disease which affects the patient for many years and there is no radical cure for the disease. To explore a possible way to treat children with refractory SLE, the authors treated 2 children with grade III and IV lupus nephropathy for 5 yea...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Zhonghua er ke za zhi = Chinese journal of pediatrics. - 1960. - 41(2003), 6 vom: 29. Juni, Seite 426-9
1. Verfasser: Chen, Jing (VerfasserIn)
Weitere Verfasser: Gu, Long-jun, Zhao, Hui-jun, Xue, Hui-liang, Zheng, Yi, Xie, Xiao-juan, Li, Li, Xu, Chong, Wang, Yao-ping
Format: Aufsatz
Sprache:Chinese
Veröffentlicht: 2003
Zugriff auf das übergeordnete Werk:Zhonghua er ke za zhi = Chinese journal of pediatrics
Schlagworte:Case Reports English Abstract Journal Article Antigens, CD34
LEADER 01000caa a22002652 4500
001 NLM144544377
003 DE-627
005 20250205070201.0
007 tu
008 231223s2003 xx ||||| 00| ||chi c
028 5 2 |a pubmed25n0482.xml 
035 |a (DE-627)NLM144544377 
035 |a (NLM)14748997 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a chi 
100 1 |a Chen, Jing  |e verfasserin  |4 aut 
245 1 0 |a Application of CD34+ autologous peripheral progenitor cell transplant in the treatment of children with refractory SLE 
264 1 |c 2003 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 06.05.2004 
500 |a Date Revised 07.06.2016 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a OBJECTIVE: Systematic lupus erythematosis (SLE) is a severe disease which affects the patient for many years and there is no radical cure for the disease. To explore a possible way to treat children with refractory SLE, the authors treated 2 children with grade III and IV lupus nephropathy for 5 years and 7 years respectively, mainly presented with persistent thrombocytopenia, proteinuria, pleural effusion with CD34(+) autologous peripheral progenitor cells transplantation 
520 |a METHODS: Mobilized with G-CSF and collected with CS-3000 Cell Separator, passed through the CliniMacs CD34(+) cell selection device, the count of CD34(+) cells obtained reached 1.0 x 10(6)/kg and 1.7 x 10(6)/kg, respectively with the remaining of 2.0 x 10(5)/kg and 1.0 x 10(4)/kg of CD3(+) cells individually. The selected CD34(+) cells were frozen at -80 degrees C. The conditioning regimen consisted of cyclophosphamide [50 mg/(kg x day) for 4 days] plus ATG [Fresennius S 5 mg/(kg x day) for 3 days]. After 48 h treatment with cyclophosphamide, the frozen stem cells were infused back to the patients 
520 |a RESULTS: Neutrophils recovered on 9 and 7 days after transplantation respectively in these 2 cases. Beginning from 15 days, the platelet count recovered and remained at over 100 x 10(9)/L. The sign of Cushing's syndrome disappeared completely 3 months after transplantation because discontinuing the steroid. One child's height had a 5 cm increase within 6 months after stopping steroid and this was the first height gain during the 7 years since she had had the disease. Till this paper was written, these 2 children were followed up for 13 months and 6 months, respectively, all the original symptoms and autoantibodies related to autoimmune disorders disappeared. But the cell-mediated immunity did not recover yet with the CD4(+) cell level still remained at a lower level 
520 |a CONCLUSION: The effect of CD34(+) autologous peripheral progenitor cell transplantation on the children with refractory SLE was satisfactory so far, but the long-term effect remains to be confirmed by further studies on more cases 
650 4 |a Case Reports 
650 4 |a English Abstract 
650 4 |a Journal Article 
650 7 |a Antigens, CD34  |2 NLM 
700 1 |a Gu, Long-jun  |e verfasserin  |4 aut 
700 1 |a Zhao, Hui-jun  |e verfasserin  |4 aut 
700 1 |a Xue, Hui-liang  |e verfasserin  |4 aut 
700 1 |a Zheng, Yi  |e verfasserin  |4 aut 
700 1 |a Xie, Xiao-juan  |e verfasserin  |4 aut 
700 1 |a Chen, Jing  |e verfasserin  |4 aut 
700 1 |a Li, Li  |e verfasserin  |4 aut 
700 1 |a Xu, Chong  |e verfasserin  |4 aut 
700 1 |a Wang, Yao-ping  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Zhonghua er ke za zhi = Chinese journal of pediatrics  |d 1960  |g 41(2003), 6 vom: 29. Juni, Seite 426-9  |w (DE-627)NLM136249191  |x 0578-1310  |7 nnns 
773 1 8 |g volume:41  |g year:2003  |g number:6  |g day:29  |g month:06  |g pages:426-9 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_20 
912 |a GBV_ILN_22 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_50 
912 |a GBV_ILN_61 
912 |a GBV_ILN_65 
912 |a GBV_ILN_69 
912 |a GBV_ILN_70 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_130 
912 |a GBV_ILN_227 
912 |a GBV_ILN_244 
912 |a GBV_ILN_285 
912 |a GBV_ILN_294 
912 |a GBV_ILN_350 
912 |a GBV_ILN_665 
912 |a GBV_ILN_813 
951 |a AR 
952 |d 41  |j 2003  |e 6  |b 29  |c 06  |h 426-9